Statement on the passing of José Baselga
AstraZeneca today issued the following statement from Pascal Soriot, Chief Executive Officer. “We are deeply saddened by the news that José Baselga, Executive Vice President Oncology R&D, and member of our Senior Executive Team, has passed away. An outstanding scientific leader, José leaves a lasting legacy in the scientific community and here at AstraZeneca. He set our Oncology R&D function on a remarkable trajectory, and his visionary leadership, deep scientific expertise and strategic insight have delivered so many achievements that we can all be proud of and that will benefit